Konu "NAFLD" için PubMed İndeksli Yayınlar Koleksiyonu listeleme
Toplam kayıt 4, listelenen: 1-4
-
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
(Springer, 2024)Metabolic dysfunction associated fatty liver disease (MAFLD) is an increasing public health problem, affecting one third of the global population. Contrary to conventional wisdom, MAFLD is not exclusive to obese or overweight ... -
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
(Elsevier, 2023)The principal limitations of the terms nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. ... -
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
(Elsevier, 2023)The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient ... -
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa
(Wiley, 2024)Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is common and closely associated with type 2 diabetes (T2D). We assessed ...